Liraglutide Effectiveness in Preoperative Weight-loss for Bariatric-metabolic Surgery

Sponsor
Hospital Civil Juan I. Menchaca
Study ID
NCT06201819
Phase
PHASE4
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

Study Details

Severe obesity is associated with considerable reduction of wellbeing and life expectancy. People living with severe obesity tend to die 8 to 10 years earlier. Preoperative management of patients living with severe obesity can be challenging and proper weight-loss may help obtain better outcomes and less morbidity. The effectiveness of GLP-1 analogue Liraglutide in preoperative weight-loss was evaluated in the study.

Key Dates

Start date
Dec 18, 2022
Status verified
Jan 2024
Primary completion
Mar 18, 2023
Completion
May 1, 2023

Study Design

Enrollment
37 participants (actual)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Patients with morbid obesity in bariatric surgery preparation protocol
    All patients with body mass index \>48 kg/m2 in preoperative protocol for bariatric surgery using liraglutide for preoperative weight loss

Primary Outcome Measure

Preoperative weight changes [ Time Frame: 3 months ]

Related Studies